1. Home
  2. GDTC vs NOTE Comparison

GDTC vs NOTE Comparison

Compare GDTC & NOTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CytoMed Therapeutics Limited

GDTC

CytoMed Therapeutics Limited

HOLD

Current Price

$1.55

Market Cap

24.8M

Sector

Health Care

ML Signal

HOLD

Logo FiscalNote Holdings Inc.

NOTE

FiscalNote Holdings Inc.

HOLD

Current Price

$1.56

Market Cap

27.5M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
GDTC
NOTE
Founded
2018
2013
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
24.8M
27.5M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
GDTC
NOTE
Price
$1.55
$1.56
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$29.25
AVG Volume (30 Days)
37.7K
248.4K
Earning Date
04-24-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$573,193.00
$102,673,000.00
Revenue This Year
$5.37
N/A
Revenue Next Year
N/A
$0.55
P/E Ratio
N/A
N/A
Revenue Growth
63.03
N/A
52 Week Low
$1.38
$1.53
52 Week High
$4.05
$24.36

Technical Indicators

Market Signals
Indicator
GDTC
NOTE
Relative Strength Index (RSI) 42.83 28.50
Support Level $1.49 $1.63
Resistance Level $1.63 $1.73
Average True Range (ATR) 0.13 0.15
MACD 0.00 0.04
Stochastic Oscillator 27.03 7.84

Price Performance

Historical Comparison
GDTC
NOTE

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

About NOTE FiscalNote Holdings Inc.

FiscalNote Holdings Inc is a provider of world-wide policy and market intelligence solutions. Leveraging AI and analytics, it delivers actionable legal and policy insights for businesses, government institutions, and nonprofits. Its suite of products includes FiscalNote Core, CQ Federal, and EU Issue Tracker, facilitating effective policy management and risk mitigation. With its analysis from FrontierView, Oxford Analytica, and Dragonfly Eye, it offers geopolitical and market intelligence services. Operating as one segment, it generates revenue by integrating policy intelligence into daily operations. Geographically the company generates the majority of its revenue from North America, Europe, Australia, and Asia, with the majority generated from North America.

Share on Social Networks: